HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017)

• Record Type: Journal Article
• Authors: Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Masetti, C.; Magni, C.F.; Micheli, V.; Paolucci, S.; Troshina, Y.; Biliotti, E.; Milana, M.; Melis, M.; Teti, E.; Lambiase, L.; Menzaghi, B.; Nicolini, L.A.; Marenco, S.; Di Maio, V.C.; Aragri, M.; Pecchioli, A.; Bertoli, A.; Antonucci, F.P.; Sarmati, L.; Sarrecchia, C.; Macera, M.; Coppola, N.; Danieli, E.; Romagnoli, D.; Pellicelli, A.; Bonora, S.; Babudieri, S.; Di Biagio, A.; Picciotto, A.; Novati, S.; Siciliano, M.; Messina, V.; Claar, E.; Baldanti, F.; Pasquazzi, C.; Ciancio, A.; Puoti, M.; Ghisetti, V.; Andreoni, M.; Taliani, G.; Rizzardini, G.; Angelico, M.; Perno, C.F.; Ceccherini-Silberstein, F.;
• Is Part Of: Digestive and liver disease. Volume 49:Issue 1(2017)Supplement
• Page Start: e53
• Publication Date: 2017-02-16
• Subjects: Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2017.01.107
• Languages: English
• ISSNs: 1590-8658